Block Listing Update

RNS Number : 7412R
Futura Medical PLC
22 November 2012
 



For immediate release

22 November 2012

 

 

Futura Medical plc

("Futura" or "the Company")

 

Block Listing Update

Futura Medical plc (AIM: FUM), the pharmaceutical group that develops innovative products for consumer healthcare, announces that, in the six months since the previous block admission update on 22 May 2012 the following changes have taken place:

Futura Medical plc Option Plan


Block Listed 25 May 2011

Block Listing Brought Forward


Options Exercised in Period


Block Listing Carried Forward









Unapproved Share Option Scheme


   814,424

   684,155


            -


   684,155









EMI Share Option Scheme


 1,520,576

   835,124


  (45,000)


   790,124











2,335,000

1,519,279


  (45,000)


1,474,279

 

 

 

For any further information please contact:

 

Futura Medical plc

 

James Barder, Chief Executive

 

Tel: +44 (0)1483 685 670

mail to: james.barder@futuramedical.com

www.futuramedical.com

 

 

Nomura Code Securities Limited

 

Phil Walker / Giles Balleny

Tel:+44 (0)20 7776 1200

 

 

 

For media enquiries please contact:

 

 

 

Buchanan Communications

 

Mark Court / Fiona Henson / Sophie Cowles

Tel: +44 (0)20 7466 5000

 

 

Notes to Editors

 

Futura Medical plc

 

Futura Medical is a pharmaceutical group that develops innovative products for consumer healthcare. The Company is developing a portfolio of products and its strategy is to license their manufacture and distribution to major pharmaceutical and healthcare groups.

 

Futura is based in Guildford, Surrey, and its shares trade on the AIM market of the London Stock Exchange.

www.futuramedical.com


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCPGGQWGUPPGMG
UK 100

Latest directors dealings